VOV.VN - Vietnam is starting phases 2 and 3 of its human clinical trial of the ARCT-154 vaccine against COVID-19 following the encouraging results of the first phase.
Vietnam’s GDP is expected to expand by about 4.8% in 2021, and the economy could converge toward the pre-pandemic GDP growth rate of 6.5% to 7% from 2022 onward, the World Bank has forecast.
VOV.VN - Ho Chi Minh City, the epicentre of the country’s prolonged COVID-19 outbreak, is taking drastic actions aimed at curbing the spread of the virus and getting its ailing economy back on track after September 30.
VOV.VN - President Nguyen Xuan Phuc has hailed the role of business associations in the United States for promoting US firms' investment in the Vietnamese market in recent years, during a meeting with business representatives and investors.
Vice President Vo Thi Anh Xuan on September 19 led a delegation to visit the Mekong Delta province of An Giang and present gifts worth close to VND14 billion (US$612,000) to support its fight against the COVID-19 pandemic.
The National Ethics Committee in Biomedical Research under the Ministry of Health on September 19 issued a press statement on its conclusions of a meeting one day earlier during which it looked into the mid-term phase 3 trial’s results of homegrown COVID-19 vaccine Nano Covax.
VOV.VN - Vietnam must devise a range of comprehensive solutions aimed at reviving its COVID ravaged economy in the post pandemic period, according to Nguyen Thi Huong, director of the Vietnam General Statistics Office (GSO).
VOV.VN - T&T PHARMA, a Vietnamese pharmaceutical joint stock company, has inked a contract to purchase 50 million doses of HIPRA, a COVID-19 vaccine produced by Spain’s HYPRA Human Health S.L.U.
Vietnam is likely to remain foreign investors’ favoured destination despite the COVID-19 resurgence ravaging across the country, The Australia Financial Review (ARF) said recently.
VOV.VN - The Advisory Council for the Registration of Circulation of Drugs and Medicinal Ingredients on August 29 did not approve Nano Covax, the first locally produced COVID-19 vaccine, and requested additional data to ensure the vaccine is completely safe and effective.